Bullish Article Restates Known Data; No Change to WAIT Rating

What happened

A Seeking Alpha article reiterates a Buy rating on Micron, arguing AI-driven memory demand outpaces supply, HBM wafer intensity tightens conventional DRAM, and Strategic Customer Agreements now cover 20% of DRAM and one-third of NAND volume with management targeting 50% coverage. These figures are not new; they mirror Micron's Q3 FY2026 disclosures (June 24, 2026) and the existing master report, which already incorporated 16 SCAs and the same coverage percentages. The article provides no fresh filings or balance-sheet evidence, only a repackaging of the company's scarcity narrative. With the stock at $1,015.80, our WAIT rating remains because the base case of $1,080 and trim level $1,150 imply limited upside, while downside to $900 is possible if backlog proof disappoints. Therefore, the news article does not change the investment thesis; the next catalysts remain the September 30, 2026 earnings, RPO/contract liability growth, and Singapore HBM ramp.

Implication

Investors should treat this article as sentiment confirmation rather than new information. The core numbers cited (20% DRAM, one-third NAND SCA coverage) were already disclosed in Micron's Q3 FY26 earnings materials and are reflected in our master report. The article's claim that the memory cycle may never be the same is an assertion that requires proof: growing remaining performance obligations (currently ~$5B), contract liabilities (~$422M), and actual customer deposits. Until those balance-sheet items step up materially, the stock's re-rating from cyclical to structural remains speculative. We would wait for sub-$900 entry or for the September 30, 2026 filing to show stronger contractual visibility before adding.

Thesis delta

No shift. The thesis remains WAIT: Micron has real AI leverage via HBM and SCAs, but the stock already prices scarcity through 2027. This article adds no new evidence to move the needle; the same checkpoints continue to govern.